Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CONMED (CNMD)

CONMED names John Gallagher CFO effective July 15, 2026

Neutral Impact 4 of 5 leadership Written later

CONMED Corporation appointed John E. Gallagher as Executive Vice President and Chief Financial Officer, effective July 15, 2026, succeeding Todd Garner, who remains with the company in an advisory role through November 2, 2026. Gallagher's pay includes a $650,000 base salary, a bonus target of 85% of base salary, and equity grants under the 2025 Long-Term Incentive Plan, which are subject to Compensation Committee approval.

Key points

  • Gallagher previously served as CFO of Certara, Inc. from April 2023 and as CFO of Cue Health Inc. from 2021 to 2023.
  • Annual base salary is $650,000, with an annual cash bonus targeted at 85% of base salary.
  • Equity grants include options with a $575,000 grant value, restricted stock units worth $1,150,000 plus $1,500,000, and performance stock units worth $575,000, subject to Compensation Committee approval.
  • Patrick Beyer stops serving as interim principal financial officer on the effective date and remains President and CEO.

The filing

CompanyCONMED (CNMD)
Form8-K, current report
Filed with the SECJun 17, 2026, 4:49 PM ET
Accession number0002077096-26-000203

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.